NCT05983250Phase 3Active not recruiting

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Study sponsor: Tenax Therapeutics, Inc. · TENX

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2026-06-30Actual

Enrollment · participants230Estimated

Source updated2026-07-24Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-07-24 · 1 field changed

Primary completion date

Recorded edit

− Previous value

2026-06-16

+ Updated value

2026-06-30

Check registry source

Posted 2026-07-21 · 3 fields changed

Completion date type

Recorded edit

− Previous value

Estimated

+ Updated value

Actual

Primary completion date

Recorded edit

− Previous value

2026-10

+ Updated value

2026-06-16

Recruitment status

Recorded edit

− Previous value

Recruiting

+ Updated value

Active not recruiting

Check registry source